Regulatory requirements for preparation of Dossier for registration of Pharmaceutical products in ACTD & CTD format
To prepare and compile the Dossier required for Registration of Pharmaceutical Products as per the requirements of each countries which shall be acceptable internationally to develop one regulatory approach. To avoid variation in the documents submitted in the form of dossier for registration of Pharmaceutical Products in the different countries of the world it’s important to know the requirements of Regulatory Authorities of each countries in which the Dossier is filled for the smooth Registration. This agreed upon common format in the form of CTD format and ACTD format for the technical documentation will significantly reduce the time and resources needed to compile applications for registration of human pharmaceuticals and will be more ease to submit the file having electronic database.
2. U.S. Department of Health and Human Services Food and Drug Administration, ICH; 2017 Oct.
3. The ASEAN Declaration (Bangkok Declaration) Bangkok, 8 August 1967; 2015.
4. "Background Note: Brunei Darussalam/Profile:/ Foreign Relations" US State Department; 2007.
5. "Vietnam in ASEAN: Toward Cooperation for Mutual Benefits". ASEAN Secretariat; 2011.
6. Carolyn L. Gates; Mya Than. ASEAN Enlargement: impacts and implications. Institute of Southeast Asian Studies. ISBN 981-230-081-3; 2001.
7. "Statement by the Secretary-General of ASEAN Welcoming the Kingdom of Cambodia as the Tenth Member State of ASEAN, ASEAN Secretariat; 1999.
8. ICH. The Common Technical Document [Internet]. ICH; 2019 [cited 2019 Mar 26]. Available from:
9. ICH M4S Guideline: Nonclinical Overview and Nonclinical Summaries of Module 2 and Module 4: Safety (R2) [Internet]. ICH; 2002 Dec [cited 2019 Mar 26]. Available from:
10. Jordan D. An overview of the Common Technical Document (CTD) regulatory dossier, The European Medical Writers Association, VOL.23 NO.2; 2014.
11. Badjatya J, and Bodla R. “Harmonization & advancement in pharmaceutical industry”. International Journal of Drug Regulatory Affairs, Vol. 1, no. 2, Feb. 2018, pp. 7-10,
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM